University Hospital of Torrejon Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2020
NCT04410562
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Hospital Universitario de Torrejón de Ardoz | Hospital Universitario de Torrejón,Madrid | University Hospital of Torrejon

Active Ingredients

Drugs in Phase 3 Trials (2)

acetylsalicylic acid (aspirin) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2